Pascale Richetta
Executive Vice President Head of the Bone Patient
Board of Directors
UCB
Australia
Biography
Pascale Richetta joins UCB with over 20 years of experience in the pharma and biotech industry. She has acquired impressive commercial experience managing both traditional pharmaceuticals and complex biologics. Her experience and knowledge of markets around the world is key to helping UCB prepare for future product launches. Trained as a medical doctor (MD), Pascale Richetta leads UCB’s Bone Patient Value Unit. One of her main missions is to take UCB’s investigational osteoporosis drug romosozumab through the next steps in its development and prepare for its potential launch upon approval. She is a member of the Executive Committee. Key positions Prior to UCB, Pascale held the following positions: 2013-2016 AbbVie Vice President, Western Europe and Canada In charge of a multi-billion specialty care portfolio including key biologic products Covering 19 affiliates and over 3000 staff 2004-2013 Abbott: Vice President, Western Europe and Canada 1994-2004 GSK Operations Director in France and Europe in charge of the Central Nervous System franchise 1990-1994 Ipsen Marketing Manager Tanakan®, France 1987-1990 Servier Product Manager, Stablon®, France Education 1985 University of Poitiers, France M.D. Prior trade association engagement EFPIA : Vice Chair of the Executive Committee, member of the Board EBE : Member of the Board EuropaBIO : Member of the Board Board of Directors membership 2016 to date CAPIO Board
Research Interest
Central Nervous System
